title: Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction.
authors.forename: M
authors.initials: M
authors.lastname: Dardikh
authors.forename: T
authors.initials: T
authors.lastname: Albert
authors.forename: R
authors.initials: R
authors.lastname: Masereeuw
authors.forename: J
authors.initials: J
authors.lastname: Oldenburg
authors.forename: I
authors.initials: I
authors.lastname: Novakova
authors.forename: W L
authors.initials: WL
authors.lastname: van Heerde
authors.forename: B
authors.initials: B
authors.lastname: Verbruggen
mesh_terms: D000906:Antibodies / Q000097:blood*; D001774:Blood Chemical Analysis / Q000379:methods*; D003029:Coagulants / Q000009:adverse effects / Q000097:blood / Q000276:immunology / Q000493:pharmacokinetics*; D005169:Factor VIII / Q000009:adverse effects / Q000276:immunology / Q000493:pharmacokinetics*; D006207:Half-Life; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance; D007262:Infusions, Intravenous; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity
chemical_list: D000906:Antibodies; D003029:Coagulants; D005169:Factor VIII